Duspatalin and Urinary tract infection - a phase IV clinical study of FDA data
Urinary tract infection is found among people who take Duspatalin, especially for people who are female, 60+ old.
The phase IV clinical study analyzes which people take Duspatalin and have Urinary tract infection. It is created by eHealthMe based on reports of 319 people who have side effects when taking Duspatalin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
319 people reported to have side effects when taking Duspatalin.
Among them, 6 people (1.88%) have Urinary tract infection.
What is Duspatalin?
Duspatalin has active ingredients of mebeverine hydrochloride. It is often used in irritable bowel syndrome. eHealthMe is studying from 340 Duspatalin users for its effectiveness, alternative drugs and more.
What is Urinary tract infection?
Urinary tract infection is found to be associated with 3,979 drugs and 3,666 conditions by eHealthMe.
Number of Duspatalin and Urinary tract infection reports submitted per year:
Gender of people who have Urinary tract infection when taking Duspatalin *:
- female: 80 %
- male: 20 %
Age of people who have Urinary tract infection when taking Duspatalin *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 20 %
- 60+: 80 %
Common drugs people take besides Duspatalin *:
- Prednisolone: 3 people, 50.00%
- Primidone: 3 people, 50.00%
- Gabapentin: 3 people, 50.00%
- Isoptin: 3 people, 50.00%
- Symbicort: 3 people, 50.00%
- Cefuroxime: 3 people, 50.00%
- Simvastatin: 3 people, 50.00%
- Roflumilast: 2 people, 33.33%
- Pantoprazole: 2 people, 33.33%
- Sertraline Hydrochloride: 2 people, 33.33%
Common side effects people have besides Urinary tract infection *:
- White Blood Cell Count Increased: 3 people, 50.00%
- Breathing Difficulty: 3 people, 50.00%
- Depression: 3 people, 50.00%
- Completed Suicide (act of taking one's own life): 3 people, 50.00%
- Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 3 people, 50.00%
- Back Pain: 2 people, 33.33%
- Delirium (wild excitement): 2 people, 33.33%
- Fall: 2 people, 33.33%
- Fatigue (feeling of tiredness): 2 people, 33.33%
- Depressed Mood: 2 people, 33.33%
Common conditions people have *:
- Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 50.00%
- Depression: 2 people, 33.33%
- Type 2 Diabetes: 1 person, 16.67%
- Pain: 1 person, 16.67%
- Myosclerosis (hardening of muscle tissue): 1 person, 16.67%
- Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 1 person, 16.67%
- High Blood Pressure: 1 person, 16.67%
- Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 1 person, 16.67%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 16.67%
- Gastritis - Chronic (long lasting inflammation of stomach): 1 person, 16.67%
* Approximation only. Some reports may have incomplete information.
Do you take Duspatalin and have Urinary tract infection?Check whether Urinary tract infection is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Urinary tract infection and when was it recovered:
Expand to all the drugs that have ingredients of mebeverine hydrochloride:
Alternative drugs to, pros and cons of Duspatalin:
- Duspatalin (340 reports)
Urinary tract infection treatments and more:
- Urinary tract infection (239,221 reports)
COVID vaccines that are related to Urinary tract infection:
- Urinary tract infection in Moderna COVID Vaccine
- Urinary tract infection in Pfizer BioNTech Covid Vaccine
- Urinary tract infection in Johnson and Johnson Covid Vaccine
Common drugs associated with Urinary tract infection:
- Prednisone: 13,893 reports
- Aspirin: 11,407 reports
- Methotrexate: 10,843 reports
- Humira: 10,333 reports
- Tysabri: 9,886 reports
- Enbrel: 8,350 reports
- Omeprazole: 7,993 reports
- Metformin: 7,374 reports
- Vitamin d: 6,742 reports
- Gabapentin: 6,625 reports
All the drugs that are associated with Urinary tract infection:
- Urinary tract infection (3,979 drugs)
Common conditions associated with Urinary tract infection:
- Multiple sclerosis: 26,759 reports
- Rheumatoid arthritis: 23,040 reports
- High blood pressure: 10,386 reports
- Pain: 6,998 reports
- Osteoporosis: 6,846 reports
All the conditions that are associated with Urinary tract infection:
- Urinary tract infection (3,666 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on mebeverine hydrochloride (the active ingredients of Duspatalin) and Duspatalin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Multaq vs. Cartia Xt - 2 seconds ago
- Fluocinolone Acetonide and Vitamin E drug interaction - 3 seconds ago
- Nasalcrom vs. Zantac 150 - 3 seconds ago
- Butalbital, Acetaminophen And Caffeine vs. Naproxen Sodium - 5 seconds ago
- Nasonex and Vusion drug interaction - 5 seconds ago
- Eosinophil Percentage Abnormal and moderna covid vaccine - 6 seconds ago
- Nefazodone Hydrochloride vs. Tramadol - 9 seconds ago
- Nasacort Allergy 24 Hour vs. Ranitidine - 11 seconds ago
- Soma and Injection Site Papule - 12 seconds ago
- Glyburide and Solu-Medrol drug interaction - 14 seconds ago